Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADSC and Laser Therapy for Scars and Cutis Laxa
NCT03887208Phase 2Completed
- Sponsor
- Medical University of Warsaw
- Start
- Jan 2018
- Primary completion
- Jan 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of autologous adipose-derived mesenchymal stromal cells in scar and cutis laxa, sponsored by Medical University of Warsaw. Primary endpoint: Change in patient's skin condition at 27 weeks. Started Jan 2018; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
scarcutis laxa
Beyond the preview
Go deeper on NCT03887208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03887208.